Clinical Trial Update: Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial update for the density-lowering effect of OFS add-on to TMX in invasive breast cancer (DELFINO). Status not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Invasive

Drugs mentioned

• OFS add-on to TMX

Snippet

Sponsor: Seoul National University Hospital | Conditions: Breast Cancer Invasive | Phase 3 | Status: UNKNOWN